Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 29 | 2021 | 245 | 5.820 |
Why?
|
| Proteins | 13 | 2020 | 777 | 2.100 |
Why?
|
| Software | 11 | 2021 | 654 | 1.930 |
Why?
|
| Glycoproteins | 7 | 2017 | 234 | 1.740 |
Why?
|
| Lipid Bilayers | 13 | 2017 | 134 | 1.480 |
Why?
|
| Cell Membrane | 7 | 2018 | 666 | 1.410 |
Why?
|
| Computer Graphics | 8 | 2016 | 100 | 1.410 |
Why?
|
| Polysaccharides | 6 | 2019 | 89 | 1.330 |
Why?
|
| Databases, Protein | 8 | 2019 | 52 | 1.310 |
Why?
|
| User-Computer Interface | 9 | 2018 | 185 | 1.100 |
Why?
|
| Molecular Docking Simulation | 3 | 2020 | 46 | 0.980 |
Why?
|
| Models, Molecular | 14 | 2019 | 1286 | 0.920 |
Why?
|
| Internet | 8 | 2014 | 312 | 0.850 |
Why?
|
| Lipopolysaccharides | 4 | 2018 | 286 | 0.830 |
Why?
|
| Trehalose | 1 | 2020 | 4 | 0.780 |
Why?
|
| Glycoconjugates | 2 | 2019 | 10 | 0.760 |
Why?
|
| Sucrose | 1 | 2020 | 64 | 0.750 |
Why?
|
| Arginine | 1 | 2020 | 136 | 0.740 |
Why?
|
| Excipients | 1 | 2020 | 49 | 0.720 |
Why?
|
| Drug Compounding | 1 | 2020 | 78 | 0.710 |
Why?
|
| Ligands | 9 | 2020 | 433 | 0.710 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 456 | 0.660 |
Why?
|
| Biological Products | 1 | 2020 | 143 | 0.650 |
Why?
|
| Glucans | 1 | 2018 | 9 | 0.640 |
Why?
|
| Carbohydrates | 3 | 2019 | 47 | 0.610 |
Why?
|
| Computational Biology | 5 | 2019 | 528 | 0.560 |
Why?
|
| Oligosaccharides | 1 | 2015 | 24 | 0.540 |
Why?
|
| Protein Conformation | 9 | 2019 | 881 | 0.540 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 3 | 2009 | 26 | 0.500 |
Why?
|
| Potassium Channel Blockers | 3 | 2009 | 64 | 0.500 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1376 | 0.490 |
Why?
|
| Membrane Proteins | 4 | 2015 | 1196 | 0.470 |
Why?
|
| Databases, Chemical | 1 | 2012 | 3 | 0.450 |
Why?
|
| Cholesterol | 2 | 2010 | 356 | 0.410 |
Why?
|
| Solvents | 5 | 2017 | 96 | 0.400 |
Why?
|
| Carbohydrate Conformation | 5 | 2019 | 18 | 0.380 |
Why?
|
| Binding Sites | 7 | 2023 | 1098 | 0.370 |
Why?
|
| Promethazine | 1 | 2009 | 4 | 0.360 |
Why?
|
| Yeasts | 1 | 2009 | 49 | 0.350 |
Why?
|
| Histamine H1 Antagonists | 1 | 2009 | 40 | 0.350 |
Why?
|
| Thermodynamics | 7 | 2023 | 309 | 0.340 |
Why?
|
| Protein Binding | 8 | 2020 | 1456 | 0.330 |
Why?
|
| Carbohydrate Sequence | 4 | 2015 | 20 | 0.320 |
Why?
|
| Ion Channels | 2 | 2023 | 246 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2015 | 318 | 0.290 |
Why?
|
| Static Electricity | 4 | 2012 | 89 | 0.290 |
Why?
|
| Capsid Proteins | 3 | 2015 | 32 | 0.280 |
Why?
|
| Kinetics | 3 | 2020 | 1513 | 0.270 |
Why?
|
| Escherichia coli | 4 | 2018 | 597 | 0.260 |
Why?
|
| High-Throughput Screening Assays | 2 | 2023 | 55 | 0.250 |
Why?
|
| Micelles | 2 | 2014 | 47 | 0.240 |
Why?
|
| Entropy | 2 | 2015 | 38 | 0.230 |
Why?
|
| Amino Acid Sequence | 6 | 2015 | 2062 | 0.220 |
Why?
|
| Computer Simulation | 6 | 2020 | 1078 | 0.220 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2012 | 30 | 0.210 |
Why?
|
| Human Immunodeficiency Virus Proteins | 2 | 2011 | 3 | 0.210 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2011 | 23 | 0.200 |
Why?
|
| Amino Acids | 2 | 2020 | 252 | 0.200 |
Why?
|
| Viscosity | 1 | 2020 | 46 | 0.190 |
Why?
|
| Protein Stability | 1 | 2020 | 99 | 0.190 |
Why?
|
| Protein Structure, Secondary | 5 | 2012 | 330 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 86 | 0.190 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 3030 | 0.180 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2020 | 81 | 0.180 |
Why?
|
| Water | 3 | 2015 | 277 | 0.170 |
Why?
|
| Glycolipids | 1 | 2018 | 29 | 0.170 |
Why?
|
| Benzene Derivatives | 1 | 2018 | 7 | 0.170 |
Why?
|
| Xylenes | 1 | 2018 | 3 | 0.170 |
Why?
|
| Muramidase | 1 | 2018 | 34 | 0.170 |
Why?
|
| Algorithms | 3 | 2018 | 1830 | 0.170 |
Why?
|
| Protein Interaction Mapping | 1 | 2019 | 82 | 0.160 |
Why?
|
| Scattering, Small Angle | 1 | 2018 | 35 | 0.160 |
Why?
|
| X-Ray Diffraction | 1 | 2018 | 124 | 0.150 |
Why?
|
| Gram-Negative Bacteria | 1 | 2016 | 35 | 0.150 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 19 | 0.140 |
Why?
|
| Bacterial Proteins | 3 | 2019 | 864 | 0.140 |
Why?
|
| Time Factors | 3 | 2015 | 5210 | 0.130 |
Why?
|
| Methane | 1 | 2015 | 10 | 0.130 |
Why?
|
| Glycosides | 1 | 2015 | 20 | 0.130 |
Why?
|
| Epitopes | 1 | 2015 | 255 | 0.130 |
Why?
|
| Hexosyltransferases | 1 | 2014 | 6 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 112 | 0.130 |
Why?
|
| Rotation | 2 | 2011 | 89 | 0.130 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 2 | 2015 | 9 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 2 | 2015 | 15 | 0.120 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2016 | 306 | 0.120 |
Why?
|
| Phosphatidylserines | 2 | 2015 | 20 | 0.120 |
Why?
|
| Sequence Alignment | 1 | 2015 | 351 | 0.120 |
Why?
|
| Phosphatidylcholines | 2 | 2015 | 48 | 0.120 |
Why?
|
| Asparagine | 1 | 2013 | 29 | 0.110 |
Why?
|
| Animals | 5 | 2019 | 26582 | 0.110 |
Why?
|
| Xenopus laevis | 2 | 2009 | 137 | 0.110 |
Why?
|
| Dimyristoylphosphatidylcholine | 2 | 2011 | 11 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2012 | 369 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2011 | 22 | 0.100 |
Why?
|
| Connexins | 1 | 2012 | 200 | 0.090 |
Why?
|
| Pyrroles | 1 | 2011 | 184 | 0.090 |
Why?
|
| Humans | 13 | 2020 | 86643 | 0.090 |
Why?
|
| Guinea Pigs | 1 | 2009 | 171 | 0.090 |
Why?
|
| Electrons | 1 | 2009 | 49 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 324 | 0.090 |
Why?
|
| Papaverine | 1 | 2008 | 5 | 0.090 |
Why?
|
| Automation | 1 | 2009 | 106 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 645 | 0.080 |
Why?
|
| Mathematical Computing | 1 | 2008 | 21 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 381 | 0.080 |
Why?
|
| Oocytes | 1 | 2009 | 221 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2011 | 370 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 152 | 0.080 |
Why?
|
| Monte Carlo Method | 2 | 2019 | 185 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 696 | 0.080 |
Why?
|
| Cell Line | 2 | 2009 | 2468 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 187 | 0.080 |
Why?
|
| HIV Infections | 1 | 2015 | 772 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 275 | 0.070 |
Why?
|
| Action Potentials | 1 | 2009 | 573 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2705 | 0.060 |
Why?
|
| Mutation | 3 | 2012 | 3968 | 0.060 |
Why?
|
| RNA | 1 | 2008 | 560 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2023 | 77 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2023 | 103 | 0.060 |
Why?
|
| DNA | 1 | 2008 | 1294 | 0.050 |
Why?
|
| Permeability | 2 | 2012 | 137 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2014 | 287 | 0.050 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2020 | 11 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 12 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 21 | 0.050 |
Why?
|
| Allosteric Site | 1 | 2020 | 23 | 0.050 |
Why?
|
| Benzene | 1 | 2019 | 8 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 36 | 0.050 |
Why?
|
| Bridged-Ring Compounds | 1 | 2019 | 13 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2020 | 46 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2019 | 92 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 113 | 0.040 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2018 | 8 | 0.040 |
Why?
|
| CD59 Antigens | 1 | 2018 | 17 | 0.040 |
Why?
|
| Campylobacter jejuni | 1 | 2018 | 14 | 0.040 |
Why?
|
| Bacteriophage T4 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 115 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2019 | 48 | 0.040 |
Why?
|
| Quantum Theory | 1 | 2018 | 28 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 93 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 162 | 0.040 |
Why?
|
| Micrococcal Nuclease | 1 | 2017 | 8 | 0.040 |
Why?
|
| Sugars | 1 | 2017 | 3 | 0.040 |
Why?
|
| ERG1 Potassium Channel | 2 | 2008 | 14 | 0.040 |
Why?
|
| Peptides | 2 | 2011 | 639 | 0.040 |
Why?
|
| Machine Learning | 1 | 2019 | 232 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 493 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2015 | 16 | 0.030 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 9 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2015 | 25 | 0.030 |
Why?
|
| HIV | 1 | 2015 | 46 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 129 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 814 | 0.030 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2015 | 2 | 0.030 |
Why?
|
| Aspergillus | 1 | 2015 | 9 | 0.030 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2014 | 6 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2014 | 21 | 0.030 |
Why?
|
| Leucine | 1 | 2014 | 67 | 0.030 |
Why?
|
| Solutions | 1 | 2014 | 85 | 0.030 |
Why?
|
| Phospholipid Ethers | 1 | 2013 | 4 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2013 | 25 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2013 | 28 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2013 | 96 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1961 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 269 | 0.030 |
Why?
|
| Drug Stability | 1 | 2012 | 48 | 0.030 |
Why?
|
| Connexin 26 | 1 | 2012 | 17 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 59 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2011 | 34 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2012 | 122 | 0.030 |
Why?
|
| Ion Transport | 1 | 2011 | 81 | 0.030 |
Why?
|
| Deuterium | 1 | 2011 | 33 | 0.030 |
Why?
|
| Alanine | 1 | 2011 | 85 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2011 | 134 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 304 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2011 | 111 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 339 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 124 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 673 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 736 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 388 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 560 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2008 | 435 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 896 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 64 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 144 | 0.020 |
Why?
|
| Female | 1 | 2009 | 44532 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 408 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2426 | 0.020 |
Why?
|